Media Newsroom of

Glauconix-Biosciences

257 fuller road
albany, NY 12203

Accelerating and de-risking ophthalmic drug development

Glauconix Biosciences Announces Appointment of Mrs. Kimberly Southern as Chief Operating Officer

Glauconix Biosciences Announces Appointment of Mrs. Kimberly Southern as Chief Operating Officer

​​Glauconix Biosciences, Inc., a specialty pharmaceutical company that uses its patented platform technology to develop human 3D ocular tissues that mimic the fluid dynamics in the eye to expedite and de-risk the R&D of ophthalmic treatments, announced today the appointment…

Glauconix Biosciences Completes Pilot Study Using Nemus Biosciences' Bioengineered Cannabinoid-Based Compound for Glaucoma Treatment

Glauconix Biosciences Completes Pilot Study Using Nemus Biosciences' Bioengineered Cannabinoid-Based Compound for Glaucoma Treatment

Glauconix Biosciences Inc., a specialty pharmaceutical company that uses its patented platform technology to develop human 3D ocular tissues that mimic the fluid dynamics in the eye to expedite and de-risk the R&D of ophthalmic treatments while reducing development costs, announced…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or Signup using Email

Already have an account ? Login

Reset Password

Already have an account ? Login